Correlation between expression of urokinase-type plasminogen activator receptor and metastasis in gastric carcinoma

Oncology Reports

Volumn 4, Issue 6, 1997, Pages 1229-1234

  Yonemura, Yutaka ^a   Nojima, Naomi ^a   Kawamura, Taiichi ^a   Ajisaka, Hideyuki ^a   Taniguchi, Keizou ^a   Fujimura, Takashi ^a   Fujita, Hideto ^a   Bandou, Etsurou ^a   Fushida, Sachio ^a   Endou, Yoshio ^a   Obata, Tooru ^a   Sasaki, Takuma ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Gastric cancer; Plasminogen activator; Urokinase type plasminogen activator receptor

Indexed keywords

CELL RECEPTOR; UROKINASE;

ARTICLE; CANCER GRADING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR DENSITY; RISK ASSESSMENT; STOMACH BIOPSY; STOMACH CARCINOMA;

EID: 0030930564     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.4.6.1229     Document Type: Article

References (31)

1. Liotta LA, Rao CN and Barsky SH: Tumor invasion and the extracellular matrix. Lab Invest 49: 636-649, 1983.
2. Liotta LA, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an inbalance of positive and negative regulation. Cell 64: 327-336, 1991.
3. Blasi F: Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 15: 105-111, 1993.
4. Dano K, Anderson PA, Grondahl-Hansen J, Kristensen PI, Nielsen IS and Skiver L: Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44: 139-226, 1985.
5. Sloane BF and Honn KV: Cysteine proteinases and metastasis. Cancer Metastasis Rev 3: 249-263, 1984.
6. Pöllänen J, Stephena RW and Vaheri A: Directed plasminogen activation at the surface of normal and malignant cells. Adv Cancer Res 57: 273-328, 1991.
7. Stephens RW, Pöllänen J, Tapiovaara H, Leung KC, Sim PS, Salonen EM, Ronne E, Behrendt N, Dano K and Vaheri A: Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J Cell Biol 108: 1987-1995, 1989.
8. Vassalli JD, Baccino D and Belin DA: Cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J Cell Biol 100: 86-92, 1985.
9. Ellis V, Wun TC, Behrendt N, Ronne E and Dano K: Inhibition of receptor-bound urokinase by plasminogen activator inhibitors. J Biol Chem 265: 9904-9908, 1990.
10. Cubellis MV, Wun TC and Blasi F: Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J 9: 1079-1085, 1990.
11. Yonemura Y, Ninomiya I, Nojima N, Sugiyama K, Fujimura T, Tsuchihara K, Kawamura T, Kaji M, Miyazaki I, Endou Y, Tanaka M and Sasaki T: Prognostic value of urokinase-type plasminogen activators in gastric cancer. Oncol Rep 1: 765-772, 1994.
12. Noguchi-Takino M, Endou Y, Yonemura Y and Sasaki T: Relationship between expression of plasminogen activator system and metastatic ability in human cancer. Int J Oncol 8: 97-105, 1996.
13. Itoh H, Yonemura Y, Fujita H, Tsuchihara K, Kawamura T, Nojima N, Fujimura T, Nose H, Endou Y and Sasaki T: Prognostic relevance of urokinase-type plasminogen activator system and plasminogen activators PAI-1 and PAI-2 in gastric cancer. Virchows Arch Pathol 427: 487-496, 1996.
14. Sato Y, Mukai K, Watanabe S, Goto M and Shimosato Y: The AMeX method. Am J Pathol 125: 431-435, 1986.
15. Conboy JG, Chan J, Mohandas N and Kan YW: Multiple protein 4.1 isoforms produced by alternative splicing in human erythroid cells. Proc Natl Acad Sci USA 85: 9062-9065, 1988.
16. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
17. Min HY, Semnani R, Mizukami IF, Watt K, Todd RFI and Liu DY: cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J Immunol 148: 3636-3642, 1992.
18. Schneider C, Owen MJ, Banville D and Williams JG: Primary structure of transferrin receptor deduced from the mRNA sequence. Nature 311: 675-678, 1984.
19. Japanese Research Society for Gastric Cancer: The general rules for the gastric cancer study in surgery and pathology. Jpn J Surg 11: 127-139, 1981.
20. Zheng MH, Fan Y, Panicker A, Smith A, Robertson T, Wysocki S, Robbins P, Papadimitriou JM and Wood DJ: Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization. Am J Pathol 147: 1559-1566, 1995.
21. Pyke C, Ralfkiær E, Rønne E, Høyer-Hansen G, Kirkeby L and Danø K: Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer. Histopathology 24: 131-138, 1994.
22. Christensen L, Carina A, Simonsen W, Heegaard W, Moestrup S, Andersen JA and Andeasen PA: Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and a2-macroglobulin receptor in human breast carcinomas. Int J Cancer 66: 441-452, 1996.
23. Yamamoto M, Sawaya R, Mohanam S, Rao VH, Bruner JM, Nicolson GL and Rao JS: Expression and localization of urokinase-type plasminogen activator receptor in human gliomas. Cancer Res 34: 5016-5020, 1994.
24. Pyke C, Græn N, Raifkiær E, Rønne E, Høyer-Hansen G, Brünner N and Danø K: Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res 53: 1909-1915, 1993.
25. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 215: 1452-1455, 1991.
26. Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimura T, Tsuchihara K, Kawamura T, Miyazaki I, Endou Y, Yanaka M and Sasaki T: Decreased E-cadherin expression correlates with poor survival in patients with gastric cancer. Anal Cell Pathol 8: 177-190, 1995.
27. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K and Shimizu S: Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443, 1989.
28. Yonemura Y, Endou Y, Nojima N, Kawamura T, Fujita H, Kaji M, Ajisaka H, Sasaki T, Yamaguchi T, Harada S and Yamamoto H: A possible role of cytokines in the formation of peritoneal dissemination. Int J Oncol 11: 349-358, 1997.
29. Seski-Oja J, Blasi F, Leof EB and Moses HI: Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma by transforming growth factor beta. J Cell Biol 106: 451-459, 1988.
30. Lund LR, Rømer J, Rønne E, Ellis V, Blasi F and Døno K: Urokinase receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor β1 in human A549 lung carcinoma cells. EMBO J 10: 3399-3407, 1991.
31. Pepper MS, Matsumoto K, Nakamura T, Orci L and Montesano R: Hepatocyte growth factor increase urokinase-type plasminogen activator (u-PA) and uPA receptor expression in Madin-Darby canine kidney epithelial cells. J Biol Chem 267: 20493-20496, 1992.